产品名称
16:0 PEG550 PE, Avanti Research™ - A Croda Brand 880500P, powder
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 25 mg (880500P-25mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 880500P
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP([O-])(OCCNC(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O)(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[NH4+]
InChI
1S/C63H124NO22P.H3N/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-30-61(65)83-58-60(86-62(66)31-29-27-25-23-21-19-17-15-13-11-9-7-5-2)59-85-87(68,69)84-33-32-64-63(67)82-57-56-81-55-54-80-53-52-79-51-50-78-49-48-77-47-46-76-45-44-75-43-42-74-41-40-73-39-38-72-37
InChI key
VJMCGROHAQCSGJ-CSZVLRKSSA-N
General description
16:0 PEG550 PE is a polyethylene glycol (PEG) conjugated phospholipid. The molecular weight and exact mass are averages based on the polydispersity of PEG.
Biochem/physiol Actions
Polyethylene glycol (PEG) conjugated phospholipids are known to protect the steric nature of liposomes. Hence, they are commonly recommended for use in liposome formulation. PEGylated lipids are used as drug carriers. Use of highly concentrated PEG-lipids makes the possibility of mixed micelles.
Packaging
5 mL Clear Glass Sealed Ampule (880500P-25mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 3
Sirkku Hanski et al.
Biomacromolecules, 11(12), 3440-3447 (2010-10-27)
We report on highly ordered oblique self-assemblies in ionic complexes of PEGylated triple-tail lipids and cationic polypeptides, as directed by side-chain crystallization, demonstrating also reversible oblique-to-hexagonal order-order transitions upon melting of the side chains. This is achieved in bulk by
Brian J Nablo et al.
Biophysical journal, 95(3), 1157-1164 (2008-07-23)
Nonelectrolyte polymers of poly(ethylene glycol) (PEG) were used to estimate the diameter of the ion channel formed by the Bacillus anthracis protective antigen 63 (PA(63)). Based on the ability of different molecular weight PEGs to partition into the pore and
G F Peacock et al.
Drug delivery, 10(1), 29-34 (2003-01-30)
A new cholesterol-carborane conjugate (BCH) has been synthesized as a potential targeting agent for boron neutron capture therapy (BNCT) of cancers. The compound is extremely water insoluble and was formulated in two liposomal formulations to determine if the compound could
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 880500P-25MG | 04061835192465 |